Insufficient scRNA-seq data for expression of TFDP3 at single-cell level.
Insufficient scRNA-seq data for expression of TFDP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 9% | 5.63 | 40 / 459 | 34% | 1.25 | 375 / 1118 |
liver | 0% | 0 | 0 / 226 | 12% | 1.75 | 49 / 406 |
thymus | 0% | 0 | 0 / 653 | 10% | 5.05 | 59 / 605 |
skin | 0% | 0.06 | 2 / 1809 | 4% | 0.46 | 18 / 472 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.09 | 7 / 459 |
esophagus | 0% | 0 | 0 / 1445 | 1% | 0.01 | 2 / 183 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.04 | 2 / 230 |
lung | 0% | 0 | 0 / 578 | 1% | 0.08 | 8 / 1155 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.00 | 1 / 286 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 1 / 502 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.01 | 1 / 504 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.01 | 1 / 527 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 1 / 901 |
brain | 0% | 0.01 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0006974 | Biological process | DNA damage response |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TFDP3 |
Protein name | Transcription factor Dp family member 3 (Cancer/testis antigen 30) (CT30) (Hepatocellular carcinoma-associated antigen 661) |
Synonyms | HCA661 DP4 |
Description | FUNCTION: Competitive inhibitor of E2F-mediated transactivation activity. Impairs E2F-mediated cell-cycle progression from G(1) to S phase. . |
Accessions | ENST00000310125.5 Q5H9I0 |